Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Earnings for Inspire Medical Systems, Inc. (INSP)
Earnings in 2023 (TTM): $-19,906,000
According to Inspire Medical Systems, Inc.'s latest financial reports the company's current earnings (TTM) are $-19,906,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Inspire Medical Systems, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-19,906,000 | $-21,153,000 |
| 2022 | $-44,268,000 | $-44,881,000 |
| 2021 | $-41,970,000 | $-42,042,000 |
| 2020 | $-57,088,000 | $-57,203,000 |
| 2019 | $-33,203,000 | $-33,243,000 |
| 2018 | $-21,828,000 | $-21,828,000 |
| 2017 | $-17,511,000 | $-17,511,000 |
| 2016 | $-18,528,000 | $-18,528,000 |
| 2015 | $-21,337,000 | $-21,337,000 |